Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 25 Apr 2023

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network

in Hematologic Malignancies

Elisabetta Antonioli
Sofia Pilerci
Irene Attucci
Gabriele Buda
Alessandro Gozzetti
Veronica Candi
Federico Simonetti
Maria Livia Del Giudice
Sara Ciofini
Michela Staderini

Frontiers in Oncology

doi 10.3389/fonc.2023.1162990

4,936 views
5 citations

Review

Published on 24 Apr 2023

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method

in Hematologic Malignancies

Vikram Mathews
Anu Korula
Anupam Chakrapani
Dinesh Bhurani
Jina Bhattacharyya
Manju Sengar
Pankaj Malhotra
Pavan Kumar Boyella
Pawan Kumar Singh
Prasanth Ganesan

Frontiers in Oncology

doi 10.3389/fonc.2023.1171568

13,206 views
6 citations

Case Report

Published on 21 Apr 2023

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia

in Hematologic Malignancies

Xiaodong Liu
Wanting Li
Jian Xiao
Huixiu Zhong
Kun Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1165819

2,168 views
1 citation

Case Report

Published on 21 Apr 2023

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis

in Hematologic Malignancies

Ester Lovato
Concetta Gangemi
Mauro Krampera
Carlo Visco
Isacco Ferrarini

Frontiers in Oncology

doi 10.3389/fonc.2023.1108994

3,260 views
2 citations

Original Research

Published on 21 Apr 2023

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease

in Hematologic Malignancies

Mariavita Ciccarone
Paola Cavaceppi
Cristiano Tesei
Stefania Brunetti
Alessandro Pulsoni
Ombretta Annibali
Cristiano Gasparoli
Roberta Battistini
Stefan Hohaus
Sabrina Pelliccia

Frontiers in Oncology

doi 10.3389/fonc.2023.1059393

5,183 views
6 citations

Original Research

Published on 21 Apr 2023

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma

in Hematologic Malignancies

Lukas John
Kaya Miah
Axel Benner
Elias K. Mai
Katharina Kriegsmann
Michael Hundemer
Dorothee Kaudewitz
Carsten Müller-Tidow
Karin Jordan
Hartmut Goldschmidt

Frontiers in Oncology

doi 10.3389/fonc.2023.1078725

4,001 views
3 citations

Review

Published on 20 Apr 2023

Liquid biopsy in hematological malignancies: current and future applications

in Hematologic Malignancies

Donatella Talotta
Mohammad Almasri
Chiara Cosentino
Gianluca Gaidano
Riccardo Moia

Frontiers in Oncology

doi 10.3389/fonc.2023.1164517

10,056 views
21 citations

Original Research

Published on 20 Apr 2023

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

in Hematologic Malignancies

Zhe Zhuang
Ying Tian
Lei Shi
Dongmei Zou
Ru Feng
Wei-wei Tian
Hong Yu
Fei Dong
Aijun Liao
Yanping Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1028571

5,985 views
6 citations

Clinical Trial

Published on 18 Apr 2023

An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation

in Hematologic Malignancies

Ki-Yong An
Mi-Seong Yu
Wonhee Cho
Meeok Choi
Kerry S. Courneya
June-Won Cheong
Justin Y. Jeon

Frontiers in Oncology

doi 10.3389/fonc.2023.1132776

3,355 views

Review

Published on 14 Apr 2023

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale

in Hematologic Malignancies

Riccardo Masetti
Edoardo Muratore
Davide Leardini
Francesco Baccelli
Andrea Pession
Arcangelo Prete
Franco Locatelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1135350

6,566 views
2 citations

Review

Published on 14 Apr 2023

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management

in Hematologic Malignancies

Denis Miyashiro
José Antonio Sanches

Frontiers in Oncology

doi 10.3389/fonc.2023.1141108

38,229 views
55 citations

Review

Published on 12 Apr 2023

Long-term health outcomes of allogeneic hematopoietic stem cell transplantation

in Hematologic Malignancies

Amar H. Kelkar
Joseph H. Antin
Roman M. Shapiro

Frontiers in Oncology

doi 10.3389/fonc.2023.1175794

6,878 views
9 citations

Case Report

Published on 11 Apr 2023

Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms

in Hematologic Malignancies

Alexandra Ghiaur
Cristina Doran
Bogdan Ionescu
Lacramioara –Andreea Mohorea-Neata
Camelia Stancioaica
Roxana Hirjan
Aurelia Tatic
Mihaela Cirstea
Didona Vasilache
Dana Tabac

Frontiers in Oncology

doi 10.3389/fonc.2023.1095154

3,873 views
2 citations

Original Research

Published on 11 Apr 2023

Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo

in Hematologic Malignancies

David E. Spaner
Tina YuXuan Luo
Guizhi Wang
Gideon Schreiber
Daniel Harari
Yonghong Shi

Frontiers in Oncology

doi 10.3389/fonc.2023.1043694

3,714 views
8 citations

Review

Published on 06 Apr 2023

Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle

in Hematologic Malignancies

Simone Feurstein

Frontiers in Oncology

doi 10.3389/fonc.2023.1128533

6,465 views
6 citations

Review

Published on 06 Apr 2023

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

in Hematologic Malignancies

Sujoy Khan
David Allsup
Stefano Molica

Frontiers in Oncology

doi 10.3389/fonc.2023.1135812

10,592 views
8 citations

Editorial

Published on 05 Apr 2023

Editorial: The latest advances in transplantation for AML

in Hematologic Malignancies

Patrizia Chiusolo
Fabio Ciceri
Simona Sica

Frontiers in Oncology

doi 10.3389/fonc.2023.1189554

1,536 views

Review

Published on 05 Apr 2023

Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings

in Hematologic Malignancies

Fang Cheng
Qiang Li
Zheng Cui
Mei Hong
Weiming Li
Yu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1146108

7,532 views
7 citations

Case Report

Published on 31 Mar 2023

Fluid overload–associated large B-cell lymphoma with primary biliary cirrhosis: A case report

in Hematologic Malignancies

Huan Wang
Quan Zhang
Qin Liu
Xian Wu
Ke Ma

Frontiers in Oncology

doi 10.3389/fonc.2023.1145540

4,778 views
3 citations

Original Research

Published on 30 Mar 2023

A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia

in Hematologic Malignancies

Yang Yu
Hao Wang
Jing-Jing Yang
Shu Fang
Ya-Nan Wen
Yi-Fan Jiao
Kun Qian
Ning Le
Ruo-Qi Shan
Wen-Jing Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1144403

3,856 views
1 citation

Systematic Review

Published on 30 Mar 2023

Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis

in Hematologic Malignancies

Dan Cao
Zongxin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1169749

2,556 views
7 citations

Case Report

Published on 29 Mar 2023

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

in Hematologic Malignancies

Luomengjia Dai
Han Zhang
Wen Chen
Yi Xia
Shuchao Qin
Yang Shao
Jianyong Li
Yi Miao
Bingzong Li
Huayuan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1145376

3,280 views

Original Research

Published on 29 Mar 2023

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

in Hematologic Malignancies

Andrea Duminuco
Alessandra Romano
Dario Leotta
Enrico La Spina
Daniela Cambria
Anna Bulla
Vittorio Del Fabro
Daniele Tibullo
Cesarina Giallongo
Giuseppe A. Palumbo

Frontiers in Oncology

doi 10.3389/fonc.2023.1157610

2,967 views
13 citations

Original Research

Published on 28 Mar 2023

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis

in Hematologic Malignancies

Zhentian Wu
Chenyi Wang
Yao Lyu
Zheshen Lin
Ming Lu
Shixiong Wang
Bingxuan Wang
Na Yang
Yeye Li
Jianhong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1104425

3,910 views
5 citations

2,053 articles

articles

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network

Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method

Case Report: Co-existence of a novel EXOC4‐TRHDE gene fusion with PML-RARA in acute promyelocytic leukemia

Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis

Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses in 270 patients with Hodgkin’s disease

Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma

Liquid biopsy in hematological malignancies: current and future applications

Lenalidomide or bortezomib as maintenance treatment remedy the inferior impact of high-risk cytogenetic abnormalities in non-transplant patients with newly diagnosed multiple myeloma: a real-world multi-centered study in China

An 8-step approach for the systematic development of an evidence-based exercise program for patients undergoing hematopoietic stem cell transplantation

Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale

Mycosis fungoides and Sézary syndrome: clinical presentation, diagnosis, staging, and therapeutic management

Long-term health outcomes of allogeneic hematopoietic stem cell transplantation

Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms

Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo

Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

Editorial: The latest advances in transplantation for AML

Dose optimization strategy of the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib for chronic myeloid leukemia: From clinical trials to real-life settings

Fluid overload–associated large B-cell lymphoma with primary biliary cirrhosis: A case report

A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia

Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis